| Literature DB >> 24961491 |
Grégory Thiabaud1, Jonathan F Arambula, Zahid H Siddik, Jonathan L Sessler.
Abstract
In an effort to increase the stability and control the platinum reactivity of platinum-texaphyrin conjugates, two Pt(IV) conjugates were designed, synthesized, and studied for their ability to form DNA adducts. They were also tested for their anti-proliferative effects using wild-type and platinum-resistant human ovarian cancer cell lines (A2780 and 2780CP, respectively). In comparison to an analogous first-generation Pt(II) chimera, one of the new conjugates provided increased stability in aqueous environments. Using a combination of (1) H NMR spectroscopy and FAAS (flameless atomic-absorption spectrometry), it was found that the Pt(IV) center within this conjugate undergoes photoinduced reduction to Pt(II) upon exposure to glass-filtered daylight, resulting in an entity that binds DNA in a controlled manner. Under conditions in which the Pt(IV) complex is reduced to the corresponding Pt(II) species, these new conjugates demonstrated potent anti-proliferative activity in both test ovarian cancer cell lines.Entities:
Keywords: conjugates; drug design; photo-activation; platinum; texaphyrin
Mesh:
Substances:
Year: 2014 PMID: 24961491 PMCID: PMC4241752 DOI: 10.1002/chem.201403094
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236